Literature DB >> 3629517

Cardiac and noncardiac malformations: observations in a population-based study.

C Ferencz, J D Rubin, R J McCarter, J A Boughman, P D Wilson, J I Brenner, C A Neill, L W Perry, S I Hepner, J W Downing.   

Abstract

A regional case-control study of congenital cardiovascular malformations (CCVMs) searches for all live-born infants in the community in whom the cardiac diagnosis has been confirmed by echocardiography, cardiac catheterization, surgery, or autopsy. Their families are studied in comparison to those of a representative sample of resident live-born infants. Detailed descriptions of noncardiac abnormalities are obtained from physician reports and maternal interviews expanded by medical record and death certificate data. Among 1,494 cases and 1,572 controls, chromosomal abnormalities, syndromes, heritable disorders, and suspect syndromes occurred with an overwhelming excess in cases (chromosomes, P less than 10(-4); syndromes/heritable disorders, P less than .005). Abnormalities affecting chromosomes 13, 18, and 21 constituted 93% of the cytogenetic defects. Syndromes and heritable disorders were of 39 types. Nonsyndromic abnormalities were three times more frequent in cases than in controls (P less than .005). Case excesses occurred for central nervous system malformations, eye disorders, major abdominal wall defects, and abnormalities of the alimentary and urinary tracts. Severe anomalies frequent among cases were those which also occur in certain recognized syndromes, and it is suggested that paired combinations of cardiac and other midline anomalies may represent "formes frustes" of syndromes with similar though variable phenotypic expressions. Cleft lip and palate, inguinal hernia, and lower limb anomalies occurred with equal frequency, suggesting their association with CCVMs by chance alone.

Entities:  

Mesh:

Year:  1987        PMID: 3629517     DOI: 10.1002/tera.1420350311

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  20 in total

1.  Recurrence risk figures for isolated tetralogy of Fallot after screening for 22q11 microdeletion.

Authors:  M C Digilio; B Marino; A Giannotti; A Toscano; B Dallapiccola
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Risk factors for atrial septal defect.

Authors:  J Tikkanen; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

3.  An excess of tetralogy of Fallot in Malta.

Authors:  V Grech
Journal:  J Epidemiol Community Health       Date:  1998-05       Impact factor: 3.710

4.  High association of congenital heart disease with indirect inguinal hernia.

Authors:  F Oztürk; B Tander; K Baysal; F Bernay
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

5.  Causes of death to age 30 in Down syndrome.

Authors:  P A Baird; A D Sadovnick
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

Review 6.  Incidence of congenital heart disease: I. Postnatal incidence.

Authors:  J I Hoffman
Journal:  Pediatr Cardiol       Date:  1995 May-Jun       Impact factor: 1.655

Review 7.  [Interventions in congenital heart disease and their sequelae in adults].

Authors:  A A Schmaltz; U Neudorf; S Sack; O Galal
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

8.  Cardiomyopathy in infancy: observations in an epidemiologic study.

Authors:  C Ferencz; C A Neill
Journal:  Pediatr Cardiol       Date:  1992-04       Impact factor: 1.655

9.  22q11 deletions in isolated and syndromic patients with tetralogy of Fallot.

Authors:  F Amati; A Mari; M C Digilio; R Mingarelli; B Marino; A Giannotti; G Novelli; B Dallapiccola
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

10.  Morbidity in children and adolescents after surgical correction of interrupted aortic arch.

Authors:  Michael L O'Byrne; Laura Mercer-Rosa; Huaqing Zhao; Xuemei Zhang; Wei Yang; Ronn E Tanel; Bradley S Marino; Amy Cassedy; Mark A Fogel; Jack Rychik; Stephen Paridon; Elizabeth Goldmuntz
Journal:  Pediatr Cardiol       Date:  2013-09-15       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.